Perceptive Advisors - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,037,312
-1.7%
1,296,4160.0%0.77%
+13.3%
Q2 2023$23,426,237
+43.8%
1,296,4160.0%0.68%
+41.0%
Q1 2023$16,295,949
-14.3%
1,296,4160.0%0.48%
-9.9%
Q4 2022$19,005,459
-14.4%
1,296,4160.0%0.53%
-17.1%
Q3 2022$22,194,000
+17.3%
1,296,4160.0%0.64%
+8.6%
Q2 2022$18,927,000
-13.2%
1,296,4160.0%0.59%
+35.7%
Q1 2022$21,805,000
-62.6%
1,296,416
-50.0%
0.44%
-2.9%
Q4 2021$58,338,000
+108.8%
2,592,832
+100.0%
0.45%
+10.8%
Q3 2021$27,937,000
-62.8%
1,296,416
-50.0%
0.41%
-16.8%
Q2 2021$75,140,000
+82.7%
2,592,832
+100.0%
0.49%
-6.2%
Q1 2021$41,127,000
-23.2%
1,296,4160.0%0.52%
-9.6%
Q4 2020$53,580,0001,296,4160.58%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,084,370$30,432,0004.62%
Vivo Capital, LLC 2,312,368$33,761,0003.39%
Frazier Life Sciences Management, L.P. 1,787,527$26,098,0002.46%
Cormorant Asset Management, LP 1,875,000$27,375,0002.07%
Sands Capital Ventures, LLC 260,000$3,796,0001.04%
Ghost Tree Capital, LLC 120,000$1,752,0000.91%
RTW INVESTMENTS, LP 2,013,601$29,399,0000.76%
COWEN AND COMPANY, LLC 534,524$7,804,0000.75%
Perceptive Advisors 1,296,416$18,927,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,324,214$19,334,0000.40%
View complete list of TARSUS PHARMACEUTICALS INC shareholders